Regulation of LFA-1 activity through cytoskeleton remodeling and signaling components modulates the efficiency of HIV type-1 entry in activated CD4+ T lymphocytes

J Immunol. 2005 Jul 15;175(2):926-35. doi: 10.4049/jimmunol.175.2.926.

Abstract

Besides interactions between the viral envelope glycoproteins with cell surface receptors, interactions between cell-derived molecules incorporated onto virions and their ligand could also modulate HIV type-1 (HIV-1) entry inside CD4(+) T lymphocytes. Although incorporation of host ICAM-1 within HIV-1 increases both virus attachment and fusion, the precise mechanism through which this phenomenon is occurring is still unclear. We demonstrate in this study that activation of primary human CD4(+) T lymphocytes increases LFA-1 affinity and avidity states, two events promoting the early events of the HIV-1 replication cycle through interactions between virus-embedded host ICAM-1 and LFA-1 clusters. Confocal analyses suggest that HIV-1 is concentrated in microdomains rich in LFA-1 clusters that also contain CD4 and CXCR4 molecules. Experiments performed with specific inhibitors revealed that entry of HIV-1 in activated CD4(+) T cells is regulated by LFA-1-dependent ZAP70, phospholipase Cgamma1, and calpain enzymatic activities. By using laboratory and clinical strains of HIV-1 produced in primary human cells, we demonstrate the importance of the LFA-1 activation state and cluster formation in the initial step of the virus life cycle. Overall, these data provide new insights into the complex molecular events involved in HIV-1 binding and entry.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / metabolism
  • Adjuvants, Immunologic / physiology
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / enzymology
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / virology*
  • Calpain / physiology
  • Cell Adhesion / immunology
  • Cell Line
  • Cytoskeleton / immunology
  • Cytoskeleton / metabolism*
  • Cytoskeleton / virology*
  • HIV-1 / immunology*
  • HIV-1 / metabolism
  • HIV-1 / pathogenicity*
  • Humans
  • Lymphocyte Activation / drug effects
  • Lymphocyte Activation / immunology*
  • Lymphocyte Function-Associated Antigen-1 / metabolism
  • Lymphocyte Function-Associated Antigen-1 / physiology*
  • Membrane Fusion / immunology
  • Muromonab-CD3 / pharmacology
  • Phospholipase C gamma
  • Phytohemagglutinins / pharmacology
  • Protein-Tyrosine Kinases / metabolism
  • Protein-Tyrosine Kinases / physiology
  • Signal Transduction / drug effects
  • Signal Transduction / immunology*
  • Tetradecanoylphorbol Acetate / pharmacology
  • Type C Phospholipases / metabolism
  • Type C Phospholipases / physiology
  • ZAP-70 Protein-Tyrosine Kinase

Substances

  • Adjuvants, Immunologic
  • Lymphocyte Function-Associated Antigen-1
  • Muromonab-CD3
  • Phytohemagglutinins
  • Protein-Tyrosine Kinases
  • ZAP-70 Protein-Tyrosine Kinase
  • ZAP70 protein, human
  • Type C Phospholipases
  • Phospholipase C gamma
  • Calpain
  • Tetradecanoylphorbol Acetate